The global Gastroenterology market size in 2023 is 54560.1 million US dollars, and it is expected to be 83182.7 million US dollars by 2030, with a compound annual growth rate of 6.2% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Gastroenterology market include Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, and GlaxoSmithKline Plc.. The share of the top 3 players in the Gastroenterology market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Gastroenterology market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Injectable accounted for XX% of Gastroenterology market in 2023. Oral & Others share of XX%.
Crohn”s Disease accounted for XX% of the Gastroenterology market in 2023. Ulcerative Colitis accounts for XX%.
This Gastroenterology market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.
Gastroenterology market country level analysis
The countries covered in the Gastroenterology market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.
Competitive Landscape and Gastroenterology Market Share Analysis
Gastroenterology market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Gastroenterology market.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Gastroenterology industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Gastroenterology market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Gastroenterology market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Gastroenterology market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Gastroenterology business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Abbott Laboratories
Johnson & Johnson
AbbVie Inc.
Salix Pharmaceuticals
GlaxoSmithKline Plc.
ALLERGAN
Takeda Pharmaceutical Company Limited
AstraZeneca
Astellas Pharma US, Inc.
Pfizer Inc.
Types list
Injectable
Oral & Others
Application list
Crohn”s Disease
Ulcerative Colitis
GERD
IBS
Others
Table of Content
1 Market Overview
1.1 Gastroenterology Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Gastroenterology Market Size & Forecast
1.4.1 Global Gastroenterology Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Gastroenterology Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Gastroenterology Market Drivers
1.5.2 Gastroenterology Market Restraints
1.5.3 Gastroenterology Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Abbott Laboratories SWOT Analysis
2.1.3 Abbott Laboratories Gastroenterology Products and Service Offered
2.1.4 Abbott Laboratories Gastroenterology Revenue and Gross Margin
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Johnson & Johnson SWOT Analysis
2.2.3 Johnson & Johnson Gastroenterology Products and Service Offered
2.2.4 Johnson & Johnson Gastroenterology Revenue and Gross Margin
2.3 AbbVie Inc.
2.3.1 Business Overview
2.3.2 AbbVie Inc. SWOT Analysis
2.3.3 AbbVie Inc. Gastroenterology Products and Service Offered
2.3.4 AbbVie Inc. Gastroenterology Revenue and Gross Margin
2.4 Salix Pharmaceuticals
2.4.1 Business Overview
2.4.2 Salix Pharmaceuticals SWOT Analysis
2.4.3 Salix Pharmaceuticals Gastroenterology Products and Service Offered
2.4.4 Salix Pharmaceuticals Gastroenterology Revenue and Gross Margin
2.5 GlaxoSmithKline Plc.
2.5.1 Business Overview
2.5.2 GlaxoSmithKline Plc. SWOT Analysis
2.5.3 GlaxoSmithKline Plc. Gastroenterology Products and Service Offered
2.5.4 GlaxoSmithKline Plc. Gastroenterology Revenue and Gross Margin
2.6 ALLERGAN
2.6.1 Business Overview
2.6.2 ALLERGAN SWOT Analysis
2.6.3 ALLERGAN Gastroenterology Products and Service Offered
2.6.4 ALLERGAN Gastroenterology Revenue and Gross Margin
2.7 Takeda Pharmaceutical Company Limited
2.7.1 Business Overview
2.7.2 Takeda Pharmaceutical Company Limited SWOT Analysis
2.7.3 Takeda Pharmaceutical Company Limited Gastroenterology Products and Service Offered
2.7.4 Takeda Pharmaceutical Company Limited Gastroenterology Revenue and Gross Margin
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 AstraZeneca SWOT Analysis
2.8.3 AstraZeneca Gastroenterology Products and Service Offered
2.8.4 AstraZeneca Gastroenterology Revenue and Gross Margin
2.9 Astellas Pharma US, Inc.
2.9.1 Business Overview
2.9.2 Astellas Pharma US, Inc. SWOT Analysis
2.9.3 Astellas Pharma US, Inc. Gastroenterology Products and Service Offered
2.9.4 Astellas Pharma US, Inc. Gastroenterology Revenue and Gross Margin
2.10 Pfizer Inc.
2.10.1 Business Overview
2.10.2 Pfizer Inc. SWOT Analysis
2.10.3 Pfizer Inc. Gastroenterology Products and Service Offered
2.10.4 Pfizer Inc. Gastroenterology Revenue and Gross Margin
3 Global Gastroenterology Market Competition, by Manufacturer
3.1 Global Gastroenterology Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Gastroenterology Players Market Share in 2023
3.2.2 Top 6 Gastroenterology Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Gastroenterology Players Head Office, Business Provided
3.4 Gastroenterology Mergers & Acquisitions
3.5 Gastroenterology New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Gastroenterology Revenue in Value by Type (2019-2030)
4.2 Global Gastroenterology Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Gastroenterology Revenue by Application (2019-2030)
5.2 Global Gastroenterology Revenue Share by Application (2019-2030)
6 Global Gastroenterology Market Analysis by Regions
6.1 Global Gastroenterology Revenue and Market Share by Regions
6.1.1 Global Gastroenterology Revenue by Regions (2019-2030)
6.1.2 Global Gastroenterology Revenue Market Share by Regions (2019-2030)
6.2 North America Gastroenterology Revenue and Growth (2019-2030)
6.3 Europe Gastroenterology Revenue and Growth (2019-2030)
6.4 Asia Pacific Gastroenterology Revenue and Growth (2019-2030)
6.5 South America Gastroenterology Revenue and Growth (2019-2030)
6.6 Middle East and Africa Gastroenterology Revenue and Growth (2019-2030)
7 North America Gastroenterology by Country, by Type, and by Application
7.1 North America Gastroenterology Revenue by Type (2019-2030)
7.2 North America Gastroenterology Revenue by Application (2019-2030)
7.3 North America Gastroenterology Revenue and Market Share by Countries
7.3.1 North America Gastroenterology Revenue in Value by Country (2019-2030)
7.3.2 United States Gastroenterology Revenue and Growth (2019-2030)
7.3.3 Canada Gastroenterology Revenue and Growth (2019-2030)
7.3.4 Mexico Gastroenterology Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Gastroenterology by Country, by Type, and by Application
8.1 Europe Gastroenterology Revenue by Type (2019-2030)
8.2 Europe Gastroenterology Revenue by Application (2019-2030)
8.3 Europe Gastroenterology Revenue and Market Share by Countries
8.3.1 Europe Gastroenterology Revenue in Value by Country (2019-2030)
8.3.2 Germany Gastroenterology Revenue and Growth (2019-2030)
8.3.3 France Gastroenterology Revenue and Growth (2019-2030)
8.3.4 United Kingdom Gastroenterology Revenue and Growth (2019-2030)
8.3.5 Russia Gastroenterology Revenue and Growth (2019-2030)
8.3.6 Italy Gastroenterology Revenue and Growth (2019-2030)
8.3.7 Nordic Gastroenterology Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Gastroenterology by Country, by Type, and by Application
9.1 Asia Pacific Gastroenterology Revenue by Type (2019-2030)
9.2 Asia Pacific Gastroenterology Revenue by Application (2019-2030)
9.3 Asia Pacific Gastroenterology Revenue and Market Share by Countries
9.3.1 Asia Pacific Gastroenterology Revenue in Value by Country (2019-2030)
9.3.2 China Gastroenterology Revenue and Growth (2019-2030)
9.3.3 Japan Gastroenterology Revenue and Growth (2019-2030)
9.3.4 Korea Gastroenterology Revenue and Growth (2019-2030)
9.3.5 India Gastroenterology Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Gastroenterology Revenue and Growth (2019-2030)
9.3.7 Australia Gastroenterology Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Gastroenterology by Country, by Type, and by Application
10.1 South America Gastroenterology Revenue by Type (2019-2030)
10.2 South America Gastroenterology Revenue by Application (2019-2030)
10.3 South America Gastroenterology Revenue and Market Share by Countries
10.3.1 South America Gastroenterology Revenue in Value by Country (2019-2030)
10.3.2 Brazil Gastroenterology Revenue and Growth (2019-2030)
10.3.3 Argentina Gastroenterology Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Gastroenterology by Country, by Type, and by Application
11.1 Middle East & Africa Gastroenterology Revenue by Type (2019-2030)
11.2 Middle East & Africa Gastroenterology Revenue by Application (2019-2030)
11.3 Middle East & Africa Gastroenterology Revenue and Market Share by Countries
11.3.1 Middle East & Africa Gastroenterology Revenue in Value by Country (2019-2030)
11.3.2 Turkey Gastroenterology Revenue and Growth (2019-2030)
11.3.3 Egypt Gastroenterology Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Gastroenterology Revenue and Growth (2019-2030)
11.3.5 UAE Gastroenterology Revenue and Growth (2019-2030)
11.3.6 South Africa Gastroenterology Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Gastroenterology Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Gastroenterology Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer